CareersInvestor RelationsPress RoomCOVID-19
Login
  1. Home
  2. Laboratory Diagnostics
  3. Assays by Diseases & Conditions
  4. Liver Fibrosis – ELF
  5. Liver Disease Education

Liver Disease Education

Expert Perspectives on Guideline Updates for NASH

Recently, the American Association of Clinical Endocrinology and the American Association for the Study of Liver Diseases released guideline updates on nonalcoholic steatohepatitis (NASH). How will these updates impact clinical practice? Drs. Zobair M.Younossi and Scott D. Isaacs join Dr. Charles Turck to share their insights on these updated guidelines.
 

Exploring AACE Updates on the Management of NAFLD & NASH

The American Association of Clinical Endocrinology (AACE) released new recommendations for the diagnosis and management of NAFLD and NASH. To learn more about these updates, Dr. John Buse speaks with Dr. Kenneth Cusi, who is the Chief of the Division of Endocrinology, Diabetes and Metabolism in the Department of Medicine at the University of Florida.
 

Medscape Education Diabetes & Endocrinology

Implementing Best Practices in Fatty Liver Disease

 06/23/2022

In this Medscape activity, Dr. Cusi summarizes key points on the diagnosis and treatment strategies of NAFLD

Naim Alkhouri, M.D.
VP of Academic Affairs, Chief of Transplant Hepatology, and Director of the Fatty Liver Program
Arizona Liver Health (ALH) in Phoenix, AZ

The ELF Test: A Novel Noninvasive Test to Determine Severity & Prognosis of NASH

 03/23/2022
Dr. Zobair M. Younossi in his office
Dr. Zobair M. Younossi
Professor and Chairman of Medicine
Inova Fairfax Medical Campus, Virginia

The U.S. Economic Burden of Nonalcoholic Steatohepatitis (NASH)

 12/10/2021

Noninvasive tests provide an important tool to help reduce healthcare costs. 

Dr. Scott D. Isaacs
Dr. Scott D. Isaacs, MD, FACP, FACE
Endocrinologist and Obesity Medicine Specialist

Atlanta Endocrine Associates, Atlanta, Georgia

NASH Prevalence in Type 2 Diabetes Patients and Use of Noninvasive Tests

 12/10/2021

How do endocrinologists manage type 2 diabetes patients with NAFLD/NASH?

Dr.Mazen Noureddin
Director of Fatty Liver Program

Cedars Sinai, Los Angeles, CA

Noninvasive Prognostic Tests in NASH Patient Management


 12/10/2021

How noninvasive tests such as the ELF™ Test are changing the field.

H. Roma Levy, MS
Clinical Expert, Liver Disease Global Clinical Marketing, Siemens Healthineers

The ELF Test & Unmet Challenges of Growing NASH Epidemic

 10/27/2021

The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.

Learn more

Subscription Button Icon

Subscribe to news from Siemens Healthineers USA

Be the first to know about our events, training, and news